014491771	014491771	CD	B-NP	O
|	|	NN	I-NP	O
GTMHO	GTMHO	NN	I-NP	O
|	|	NN	I-NP	O
48970452	48970452	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0425665	0425665	CD	B-NP	O
|	|	CC	I-NP	O
11/20/2004	11/20/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
CONGESTIVE	CONGESTIVE	NNP	I-NP	O
HEART	HEART	NNP	I-NP	O
FAILURE	FAILURE	NNP	I-NP	O
,	,	,	O	O
CARDIOMYOPATHY	CARDIOMYOPATHY	NNP	B-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/23/2004	5/23/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/16/2004	10/16/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MILFORD	MILFORD	NNP	B-NP	O
WIZWER	WIZWER	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
36-year-old	36-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
familial	familial	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
estimated	estimate	VBN	B-VP	O
at	at	IN	B-PP	O
around	around	IN	B-NP	O
15	15	CD	I-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
marked	marked	JJ	B-NP	O
left	left	JJ	I-NP	O
and	and	CC	I-NP	O
right	right	JJ	I-NP	O
chamber	chamber	NN	I-NP	O
enlargement	enlargement	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
tricuspid	tricuspid	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
PA	PA	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
of	of	IN	B-PP	O
51	51	CD	B-NP	O
plus	plus	CC	O	O
right	right	JJ	B-NP	O
atrium	atrium	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
in	in	IN	B-PP	O
2003	2003	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
ICD	ICD	NN	I-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
2001	2001	CD	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
one	one	CD	I-NP	O
staircase	staircase	NN	I-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
before	before	IN	B-PP	O
becoming	become	VBG	B-VP	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
admits	admit	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
increasing	increase	VBG	I-VP	O
orthopnea	orthopnea	NN	B-NP	O
and	and	CC	I-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
nocturnal	nocturnal	JJ	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
peripheral	peripheral	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
dietary	dietary	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
intake	intake	NN	I-NP	O
and	and	CC	I-NP	O
medications	medication	NNS	I-NP	O
noncompliance	noncompliance	NN	I-NP	O
leading	lead	VBG	B-VP	O
to	to	TO	B-PP	O
heart	heart	NN	B-NP	O
failure	failure	NN	I-NP	O
exacerbations	exacerbation	NNS	I-NP	O
.	.	.	O	O

Currently	Currently	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
eating	eat	VBG	I-VP	O
``	``	``	O	O
salty	salty	NN	B-NP	O
foods	food	NNS	I-NP	O
,	,	,	O	O
''	''	''	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
drinking	drink	VBG	I-VP	O
a	a	DT	B-NP	O
lot	lot	NN	I-NP	O
of	of	IN	B-PP	O
extra	extra	JJ	B-NP	O
fluids	fluid	NNS	I-NP	O
because	because	IN	B-SBAR	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
feeling	feel	VBG	I-VP	O
dry	dry	JJ	B-ADJP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
always	always	RB	I-VP	O
taking	take	VBG	I-VP	O
his	his	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
.	.	.	O	O

Consequently	Consequently	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
noticed	notice	VBN	I-VP	O
a	a	DT	B-NP	O
worsening	worsening	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
,	,	,	O	O
worsening	worsen	VBG	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
most	most	RBS	B-ADVP	O
notably	notably	RB	I-ADVP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
girth	girth	NN	I-NP	O
.	.	.	O	O

Because	Because	IN	B-PP	O
of	of	IN	I-PP	O
these	these	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
decompensated	decompensate	VBN	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
physicians	physician	NNS	I-NP	O
suggested	suggest	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
be	be	VB	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
for	for	IN	B-PP	O
management	management	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
decompensated	decompensate	VBN	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
previously	previously	RB	B-ADVP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
transplant	transplant	NN	I-NP	O
list	list	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
delisted	deliste	VBN	I-VP	O
given	give	VBN	I-VP	O
his	his	PRP$	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
and	and	CC	I-NP	O
continuation	continuation	NN	I-NP	O
of	of	IN	B-PP	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
is	be	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
ranging	range	VBG	B-VP	O
from	from	IN	B-PP	O
1.2	1.2	CD	B-NP	O
to	to	TO	B-PP	O
3.5	3.5	CD	B-NP	O
at	at	IN	B-PP	O
times	time	NNS	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Aldactone	Aldactone	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
K-Dur	K-Dur	NNP	B-NP	O
40	40	CD	I-NP	O
mEq	mEq	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
twice	twice	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
metolazone	metolazone	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
smoking	smoke	VBG	I-VP	O
one-half	one-half	NN	B-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
cigarettes	cigarette	NNS	B-NP	O
,	,	,	O	O
occasional	occasional	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
IV	IV	CD	I-NP	O
drug	drug	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
mother	mother	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
brother	brother	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
cousin	cousin	NN	I-NP	O
and	and	CC	O	O
nephew	nephew	VB	B-VP	O
all	all	DT	O	O
have	have	VBP	B-VP	O
the	the	DT	B-NP	O
familial	familial	JJ	I-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
JVP	JVP	NN	I-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
18	18	CD	I-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
range	range	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
physical	physical	JJ	I-NP	O
examination	examination	NN	I-NP	O
with	with	IN	B-PP	O
positive	positive	JJ	B-NP	B-protein
HJR	HJR	NN	I-NP	I-protein
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
exam	exam	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
positive	positive	JJ	I-NP	O
S3	S3	NN	I-NP	O
of	of	IN	B-PP	O
laterally	laterally	RB	B-NP	O
displaced	displace	VBN	I-NP	O
PMI	PMI	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
ventricular	ventricular	JJ	I-NP	O
heave	heave	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
2/6	2/6	CD	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
distended	distend	VBN	I-VP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
likely	likely	RB	B-ADJP	O
with	with	IN	B-PP	O
ascites	ascite	NNS	B-NP	O
and	and	CC	O	O
palpable	palpable	JJ	B-NP	O
liver	liver	NN	I-NP	O
edge	edge	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
were	be	VBD	B-VP	O
warm	warm	JJ	B-ADJP	O
without	without	IN	B-PP	O
edema	edema	NN	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
From	From	IN	B-PP	O
the	the	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
initially	initially	RB	B-ADVP	O
attempted	attempt	VBD	B-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
him	him	PRP	B-NP	O
IV	IV	CD	B-NP	O
torsemide	torsemide	NN	I-NP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
well	well	RB	B-ADJP	O
enough	enough	RB	I-ADJP	O
to	to	TO	B-PP	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
therefore	therefore	RB	B-ADVP	O
we	we	PRP	B-NP	O
started	start	VBD	B-VP	O
drip	drip	NN	B-NP	O
with	with	IN	B-PP	O
Zaroxolyn	Zaroxolyn	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
stopped	stop	VBD	B-VP	O
his	his	PRP$	B-NP	O
Isordil	Isordil	NN	I-NP	O
and	and	CC	I-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
early	early	RB	B-ADVP	O
on	on	RB	I-ADVP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
blood	blood	NN	B-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
2.0	2.0	CD	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
2.2	2.2	CD	B-NP	O
with	with	IN	B-PP	O
low	low	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
start	start	VB	I-VP	O
a	a	DT	B-NP	O
low-dose	low-dose	JJ	I-NP	B-protein
dopamine	dopamine	NN	I-NP	I-protein
drips	drip	NNS	I-NP	I-protein
at	at	IN	B-PP	O
2	2	CD	B-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
was	be	VBD	B-VP	O
only	only	RB	B-NP	O
about	about	RB	I-NP	O
500	500	CD	I-NP	O
cc	cc	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
so	so	IN	O	O
we	we	PRP	B-NP	O
further	further	RB	B-ADVP	O
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
from	from	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
an	an	DT	B-NP	O
hour	hour	NN	I-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
an	an	DT	B-NP	O
hour	hour	NN	I-NP	O
after	after	IN	B-PP	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
Lasix	Lasix	NN	I-NP	O
bolus	bolus	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
this	this	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
an	an	DT	B-NP	O
hour	hour	NN	I-NP	O
and	and	CC	I-NP	O
dopamine	dopamine	NN	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
mcg	mcg	NN	I-NP	O
per	per	IN	B-PP	O
hour	hour	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
very	very	RB	B-NP	O
good	good	JJ	I-NP	O
and	and	CC	I-NP	O
effective	effective	JJ	I-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
at	at	IN	B-PP	O
approximately	approximately	RB	B-NP	O
2-3	2-3	CD	I-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
negative	negative	JJ	B-NP	O
,	,	,	O	O
also	also	RB	B-VP	O
reflected	reflect	VBN	I-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
total	total	JJ	I-NP	O
weight	weight	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
admission	admission	NN	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
around	around	IN	B-NP	O
90	90	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
each	each	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
diuresed	diurese	VBD	B-VP	O
about	about	IN	B-PP	O
an	an	DT	B-NP	O
half	half	NN	I-NP	O
to	to	TO	B-VP	O
kilo	kilo	VB	I-VP	O
off	off	RP	B-PRT	O
until	until	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
86	86	CD	I-NP	O
kg	kg	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
monitored	monitor	VBD	B-VP	O
strict	strict	JJ	B-NP	O
I	I	NN	I-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
checked	check	VBD	B-VP	O
daily	daily	JJ	B-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
diuresis	diuresis	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
levels	level	NNS	I-NP	O
were	be	VBD	B-VP	O
decreasing	decrease	VBG	I-VP	O
mostly	mostly	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
drinking	drink	VBG	B-VP	O
a	a	DT	B-NP	O
lot	lot	NN	I-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
water	water	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
combination	combination	NN	I-NP	O
of	of	IN	B-PP	O
free	free	JJ	B-NP	O
water	water	NN	I-NP	O
intake	intake	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
natriuresis	natriuresis	NN	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
further	further	JJ	B-NP	O
worsening	worsening	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hyponatremia	hyponatremia	NN	I-NP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
admission	admission	NN	I-NP	O
sodium	sodium	NN	I-NP	O
of	of	IN	B-PP	O
128	128	CD	B-NP	O
to	to	TO	B-PP	O
124	124	CD	B-NP	O
,	,	,	O	O
eventually	eventually	RB	B-ADVP	O
to	to	TO	B-PP	O
122	122	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
strictly	strictly	RB	B-ADVP	O
reinforce	reinforce	VBP	B-VP	O
the	the	DT	B-NP	O
need	need	NN	I-NP	O
to	to	TO	B-VP	O
limit	limit	VB	I-VP	O
his	his	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
intake	intake	VB	B-VP	O
to	to	TO	B-PP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
2	2	CD	I-NP	O
liters	liter	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
point	point	NN	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
sodium	sodium	NN	I-NP	O
levels	level	NNS	I-NP	O
than	than	IN	B-SBAR	O
rebounded	rebound	VBD	B-VP	O
to	to	TO	B-PP	O
124	124	CD	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
128	128	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
monitored	monitor	VBD	B-VP	O
the	the	DT	B-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
lytes	lyte	NNS	I-NP	O
.	.	.	O	O

Eventually	Eventually	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
18	18	CD	B-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
about	about	IN	B-NP	O
10	10	CD	I-NP	O
to	to	TO	I-NP	O
12	12	CD	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
good	good	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
,	,	,	O	O
thus	thus	RB	B-ADVP	O
we	we	PRP	B-NP	O
weaned	wean	VBD	B-VP	O
off	off	RP	B-PRT	O
the	the	DT	B-NP	O
dopamine	dopamine	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
continued	continue	VBD	B-VP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
more	more	JJR	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
then	then	RB	B-ADVP	O
discontinued	discontinue	VBD	B-VP	O
the	the	DT	B-NP	O
Lasix	Lasix	NNP	I-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
transitioned	transitione	VBD	B-VP	O
him	him	PRP	B-NP	O
back	back	RB	B-ADVP	O
over	over	RP	B-PRT	O
to	to	TO	B-VP	O
torsemide	torsemide	VB	I-VP	O
200	200	CD	B-NP	O
b.i.d.	b.i.d.	JJ	I-NP	O
p.o.	p.o.	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
watch	watch	VB	B-VP	O
him	him	PRP	B-NP	O
for	for	IN	B-PP	O
another	another	DT	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
then	then	RB	B-ADVP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	O	O
I	I	NNP	B-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
finally	finally	RB	B-ADVP	O
about	about	RB	B-NP	O
500	500	CD	I-NP	O
cc	cc	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
which	which	WDT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
about	about	RB	B-NP	O
1	1	CD	I-NP	O
to	to	TO	I-NP	O
2	2	CD	I-NP	O
liters	liter	NNS	I-NP	O
negative	negative	JJ	B-ADJP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
about	about	IN	B-PP	O
9	9	CD	B-NP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
at	at	IN	B-PP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
re-added	re-adde	VBD	B-VP	O
his	his	PRP$	B-NP	O
Isordil	Isordil	NN	I-NP	O
at	at	IN	B-PP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
90s	90	NNS	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-PP	O
his	his	PRP$	B-NP	O
potassium	potassium	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
always	always	RB	B-ADVP	O
borderline	borderline	JJ	B-NP	O
low	low	JJ	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
33	33	CD	I-NP	O
or	or	CC	I-NP	O
35	35	CD	I-NP	O
range	range	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
decided	decide	VBD	B-VP	O
to	to	TO	I-VP	O
increase	increase	VB	I-VP	O
his	his	PRP$	B-NP	O
Aldactone	Aldactone	NNP	I-NP	O
dose	dose	NN	I-NP	O
to	to	TO	B-PP	O
25	25	CD	B-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
but	but	CC	O	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
underlying	underlie	VBG	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
decreased	decrease	VBN	I-VP	O
his	his	PRP$	B-NP	O
standing	standing	NN	I-NP	O
K-Dur	K-Dur	NNP	I-NP	O
from	from	IN	B-PP	O
40	40	CD	B-NP	O
mEq	mEq	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
mEq	mEq	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
echo	echo	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
,	,	,	O	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
4	4	CD	B-NP	O
+	+	SYM	I-NP	O
MR.	MR.	NN	I-NP	O
They	They	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
comment	comment	VB	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
synchrony	synchrony	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
preliminary	preliminary	JJ	I-NP	O
report	report	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
Bi-V	Bi-V	NN	B-NP	O
pacing	pacing	NN	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
mildly	mildly	RB	I-NP	O
widened	widen	VBN	I-NP	O
QRS	QRS	NN	I-NP	B-protein
complex	complex	NN	I-NP	I-protein
stage	stage	NN	I-NP	O
III	III	CD	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
and	and	CC	O	O
having	have	VBG	B-VP	O
been	be	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
very	very	RB	I-NP	O
good	good	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
regimen	regimen	NN	I-NP	O
up	up	RP	B-PRT	O
until	until	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
medical	medical	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
consisted	consist	VBD	B-VP	O
of	of	IN	B-PP	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Aldactone	Aldactone	NNP	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Isordil	Isordil	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
K-Dur	K-Dur	NN	B-NP	O
20	20	CD	I-NP	O
mEq	mEq	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
also	also	RB	B-ADVP	O
added	add	VBD	B-VP	O
folate	folate	JJ	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
because	because	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
homocystine	homocystine	NN	I-NP	O
level	level	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
takes	take	VBZ	B-VP	O
Ambien	Ambien	NN	B-NP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
for	for	IN	B-PP	O
insomnia	insomnia	NN	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
with	with	IN	B-PP	O
plan	plan	NN	B-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Grassi	Grassi	NNP	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
Thyroid	Thyroid	NNP	I-NP	O
Clinic	Clinic	NNP	I-NP	O
on	on	IN	B-PP	O
3/1/05	3/1/05	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
again	again	RB	I-VP	O
urged	urge	VBN	I-VP	O
to	to	TO	I-VP	O
stop	stop	VB	I-VP	O
smoking	smoking	NN	B-NP	O
and	and	CC	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
complaint	complaint	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
regimen	regimen	NN	I-NP	O
because	because	IN	B-SBAR	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
heart	heart	NN	I-NP	O
transplant	transplant	NN	I-NP	O
candidate	candidate	NN	I-NP	O
and	and	CC	B-PP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
current	current	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
not	not	RB	I-VP	O
listed	list	VBN	I-VP	O
given	give	VBN	I-VP	O
the	the	DT	B-NP	O
aforementioned	aforementioned	JJ	I-NP	O
reasons	reason	NNS	I-NP	O
.	.	.	O	O

Overall	Overall	RB	B-ADVP	O
,	,	,	O	O
Mr.	Mr.	NNP	B-NP	O
Plagmann	Plagmann	NNP	I-NP	O
states	state	VBZ	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
have	have	VBP	B-VP	O
drastically	drastically	RB	I-VP	O
improved	improve	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
no	no	RB	B-ADVP	O
longer	longer	RBR	I-ADVP	O
has	have	VBZ	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
exert	exert	VB	I-VP	O
himself	himself	PRP	B-NP	O
much	much	RB	B-ADJP	O
more	more	JJR	I-ADJP	O
without	without	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
lightheadedness	lightheadedness	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
eager	eager	JJ	B-ADJP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
home	home	NN	B-NP	O
eScription	eScription	NN	I-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
1-0474396	1-0474396	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
BURK	BURK	NNP	B-NP	O
,	,	,	O	O
MARIANO	MARIANO	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MIRICLE	MIRICLE	NNP	B-NP	O
,	,	,	O	O
BRENDAN	BRENDAN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5597826	5597826	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
6/19/04	6/19/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
6/19/04	6/19/04	CD	B-NP	O

